Professor | Shaobo Ke | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Shaobo Ke
Contact Information	doctorhpyc@163.com
Language ability	Chinese, English
Province	Hubei

Upload Avatar (500 x 500)

Name

Shaobo Ke

Contact Information

doctorhpyc@163.com

Language ability

Chinese, English

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	2000/09–2005/07, Bachelor of Clinical Medicine, Hubei University of Science and Technology 2005/09–2007/07, Master of Surgery, First Clinical College of Wuhan University 2012/09–2015/07, PhD in Oncology, Second Clinical College of Wuhan University Led and participated in 5 national and provincial projects
Work Experience	2007/07-2012/08, Renhe Hospital affiliated to Three Gorges University, Attending Physician 2015/07-2019/10, Cancer Center, Renmin Hospital of Wuhan University, Attending Physician 2019/11-present, Cancer Center, Renmin Hospital of Wuhan University, Deputy Chief Physician and Deputy Director

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

2000/09–2005/07, Bachelor of Clinical Medicine, Hubei University of Science and Technology
2005/09–2007/07, Master of Surgery, First Clinical College of Wuhan University
2012/09–2015/07, PhD in Oncology, Second Clinical College of Wuhan University
Led and participated in 5 national and provincial projects

Work Experience

2007/07-2012/08, Renhe Hospital affiliated to Three Gorges University, Attending Physician
2015/07-2019/10, Cancer Center, Renmin Hospital of Wuhan University, Attending Physician
2019/11-present, Cancer Center, Renmin Hospital of Wuhan University, Deputy Chief Physician and Deputy Director

Areas of Focus	Tumor targeted therapy Tumor immune microenvironment regulation
Publications	Efficacy of endoscopic therapy for T1b esophageal cancer and construction of prognosis prediction model: A retrospective cohort study, Shaobo Ke et al., 2023 USP14 promotes colorectal cancer progression by targeting JNK for stabilization, Shaobo Ke et al., 2023 An exploratory clinical trial of apatinib combined with intensity modulated radiation therapy for patients with unresectable hepatocellular Carcinoma, Shaobo Ke et al., 2023 Regional Lymph Node Metastasis and Axillary Surgery of Microinvasive Breast Cancer: A Population-Based Study, Shaobo Ke et al., 2022 Evaluation of Concurrent Chemoradiotherapy in Synchronous Oligometastatic Esophageal Squamous Cell Carcinoma, Shaobo Ke et al., 2022 Knockdown of circRNA circ_0087378 represses the tumorigenesis and progression of esophageal squamous cell carcinoma through modulating the miR-140-3p/E2F3 axis, Shaobo Ke et al., 2020 ALG3 Contributes to the Malignancy of Non-small Cell Lung Cancer and Is Negatively Regulated by MiR-98-5p, Shaobo Ke et al., 2020 Therapeutic Effect of First-line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor(EGFR-TKI)Combined with Whole Brain Radiotherapy in EGFR Mutation-positive Lung Adenocarcinoma Patients with Brain Metastases, Shaobo Ke et al., 2018 Downregulation of high mobility group box 1 modulates telomere homeostasis and increases the radiosensitivity of human breast cancer cells, Shaobo Ke et al., 2015

Areas of Focus

Tumor targeted therapy
Tumor immune microenvironment regulation

Publications

Efficacy of endoscopic therapy for T1b esophageal cancer and construction of prognosis prediction model: A retrospective cohort study, Shaobo Ke et al., 2023
USP14 promotes colorectal cancer progression by targeting JNK for stabilization, Shaobo Ke et al., 2023
An exploratory clinical trial of apatinib combined with intensity modulated radiation therapy for patients with unresectable hepatocellular Carcinoma, Shaobo Ke et al., 2023
Regional Lymph Node Metastasis and Axillary Surgery of Microinvasive Breast Cancer: A Population-Based Study, Shaobo Ke et al., 2022
Evaluation of Concurrent Chemoradiotherapy in Synchronous Oligometastatic Esophageal Squamous Cell Carcinoma, Shaobo Ke et al., 2022
Knockdown of circRNA circ_0087378 represses the tumorigenesis and progression of esophageal squamous cell carcinoma through modulating the miR-140-3p/E2F3 axis, Shaobo Ke et al., 2020
ALG3 Contributes to the Malignancy of Non-small Cell Lung Cancer and Is Negatively Regulated by MiR-98-5p, Shaobo Ke et al., 2020
Therapeutic Effect of First-line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor(EGFR-TKI)Combined with Whole Brain Radiotherapy in EGFR Mutation-positive Lung Adenocarcinoma Patients with Brain Metastases, Shaobo Ke et al., 2018
Downregulation of high mobility group box 1 modulates telomere homeostasis and increases the radiosensitivity of human breast cancer cells, Shaobo Ke et al., 2015

Targeted Therapy Immunotherapy Digestive System Tumors Precision Medicine Clinical Trials Radiation Oncology Molecular Biology Cancer Research Tumor Microenvironment Immune Regulation

Rongquan Xiao - Southern University of Science and Technology

Xu Binghe - Wuhan University

Mei Liejun - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us